CLPBF Stock Coloplast AS (CLPBF, $95) RSI Indicator left the overbought zone on October 27, 2025

GET DAILY SIGNALS

Get AI intraday signals

CLPBF - Coloplast AS

RSI signal

View

Odds of DOWN Trend

Price: $95

Daily change: +$4.79 (+5.31%)

Daily volume: 55

Capitalization: $21.1B

Industry: Pharmaceuticals: Other

This is a signal that CLPBF's price could be shifting from an uptrend to a downtrend. Traders may consider selling the stock or exploring put options. A.I.dvisor looked back and found 34 similar cases where CLPBF's RSI Indicator left the overbought zone, and in of them led to a successful outcome. Odds of Success:

CLPBF in downward trend: price expected to drop as it breaks its higher Bollinger Band on October 27, 2025

CLPBF broke above its upper Bollinger Band on October 27, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options. The A.I.dvisor looked at 37 similar instances where the stock broke above the upper band. In of the 37 cases the stock fell afterwards. This puts the odds of success at .

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day RSI Indicator for CLPBF moved out of overbought territory on October 29, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 34 similar instances where the indicator moved out of overbought territory. In of the 34 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 61 cases where CLPBF's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on November 12, 2025. You may want to consider a long position or call options on CLPBF as a result. In of 79 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for CLPBF just turned positive on October 13, 2025. Looking at past instances where CLPBF's MACD turned positive, the stock continued to rise in of 44 cases over the following month. The odds of a continued upward trend are .

CLPBF moved above its 50-day moving average on November 04, 2025 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for CLPBF crossed bullishly above the 50-day moving average on November 03, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 19 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 186 cases where CLPBF Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (8.598) is normal, around the industry mean (10.242). P/E Ratio (38.132) is within average values for comparable stocks, (158.743). Projected Growth (PEG Ratio) (2.449) is also within normal values, averaging (2.733). CLPBF has a moderately high Dividend Yield (0.033) as compared to the industry average of (0.016). P/S Ratio (4.973) is also within normal values, averaging (111.072).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. CLPBF’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CLPBF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock worse than average.